These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 34830097)

  • 1. The Epithelial-to-Mesenchymal Transition (EMT) in the Development and Metastasis of Malignant Pleural Mesothelioma.
    Ramundo V; Zanirato G; Aldieri E
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APE-1/Ref-1 Inhibition Blocks Malignant Pleural Mesothelioma Cell Proliferation and Migration: Crosstalk between Oxidative Stress and Epithelial Mesenchymal Transition (EMT) in Driving Carcinogenesis and Metastasis.
    Ramundo V; Zanirato G; Palazzo ML; Riganti C; Aldieri E
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial to Mesenchymal Transition in Human Mesothelial Cells Exposed to Asbestos Fibers: Role of TGF-β as Mediator of Malignant Mesothelioma Development or Metastasis via EMT Event.
    Turini S; Bergandi L; Gazzano E; Prato M; Aldieri E
    Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30609805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGF2 and EGF induce epithelial-mesenchymal transition in malignant pleural mesothelioma cells via a MAPKinase/MMP1 signal.
    Schelch K; Wagner C; Hager S; Pirker C; Siess K; Lang E; Lin R; Kirschner MB; Mohr T; Brcic L; Marian B; Holzmann K; Grasl-Kraupp B; Krupitza G; Laszlo V; Klikovits T; Dome B; Hegedus B; Garay T; Reid G; van Zandwijk N; Klepetko W; Berger W; Grusch M; Hoda MA
    Carcinogenesis; 2018 Apr; 39(4):534-545. PubMed ID: 29635378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of epithelial-mesenchymal transition in malignant pleural mesothelioma.
    Schramm A; Opitz I; Thies S; Seifert B; Moch H; Weder W; Soltermann A
    Eur J Cardiothorac Surg; 2010 Mar; 37(3):566-72. PubMed ID: 19781955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of epithelial-mesenchymal transition-associated markers in malignant pleural mesothelioma.
    Iwanami T; Uramoto H; Nakagawa M; Shimokawa H; Yamada S; Kohno K; Tanaka F
    Oncology; 2014; 86(2):109-16. PubMed ID: 24457449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell and extracellular matrix interaction models in benign mesothelial and malignant pleural mesothelioma cells in 2D and 3D in-vitro.
    Jagirdar RM; Papazoglou ED; Pitaraki E; Kouliou OA; Rouka E; Giannakou L; Giannopoulos S; Sinis SI; Hatzoglou C; Gourgoulianis KI; Zarogiannis SG
    Clin Exp Pharmacol Physiol; 2021 Apr; 48(4):543-552. PubMed ID: 33336399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomics and Functional Genomics of Malignant Pleural Mesothelioma.
    Cakiroglu E; Senturk S
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32882916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelioid peritoneal mesothelioma: a hybrid phenotype within a mesenchymal-epithelial/epithelial-mesenchymal transition framework.
    Bozzi F; Brich S; Dagrada GP; Negri T; Conca E; Cortelazzi B; Belfiore A; Perrone F; Gualeni AV; Gloghini A; Cabras A; Brenca M; Maestro R; Zaffaroni N; Casali P; Bertulli R; Deraco M; Pilotti S
    Oncotarget; 2016 Nov; 7(46):75503-75517. PubMed ID: 27705913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular classification of malignant pleural mesothelioma: identification of a poor prognosis subgroup linked to the epithelial-to-mesenchymal transition.
    de Reyniès A; Jaurand MC; Renier A; Couchy G; Hysi I; Elarouci N; Galateau-Sallé F; Copin MC; Hofman P; Cazes A; Andujar P; Imbeaud S; Petel F; Pairon JC; Le Pimpec-Barthes F; Zucman-Rossi J; Jean D
    Clin Cancer Res; 2014 Mar; 20(5):1323-34. PubMed ID: 24443521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of the M-CSF/IL-34/CSF-1R pathway in malignant pleural mesothelioma.
    Blondy T; d'Almeida SM; Briolay T; Tabiasco J; Meiller C; Chéné AL; Cellerin L; Deshayes S; Delneste Y; Fonteneau JF; Boisgerault N; Bennouna J; Grégoire M; Jean D; Blanquart C
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Silico and In Vitro Analyses of LncRNAs as Potential Regulators in the Transition from the Epithelioid to Sarcomatoid Histotype of Malignant Pleural Mesothelioma (MPM).
    Singh AS; Heery R; Gray SG
    Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29701689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Turning back the Wheel: Inducing Mesenchymal to Epithelial Transition via Wilms Tumor 1 Knockdown in Human Mesothelioma Cell Lines to Influence Proliferation, Invasiveness, and Chemotaxis.
    Plönes T; Fischer M; Höhne K; Sato H; Müller-Quernheim J; Zissel G
    Pathol Oncol Res; 2017 Oct; 23(4):723-730. PubMed ID: 28054314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers.
    Bononi I; Comar M; Puozzo A; Stendardo M; Boschetto P; Orecchia S; Libener R; Guaschino R; Pietrobon S; Ferracin M; Negrini M; Martini F; Bovenzi M; Tognon M
    Oncotarget; 2016 Dec; 7(50):82700-82711. PubMed ID: 27716620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulated Expression of the MicroRNA miR-137 and Its Target YBX1 Contribute to the Invasive Characteristics of Malignant Pleural Mesothelioma.
    Johnson TG; Schelch K; Cheng YY; Williams M; Sarun KH; Kirschner MB; Kao S; Linton A; Klebe S; McCaughan BC; Lin RCY; Pirker C; Berger W; Lasham A; van Zandwijk N; Reid G
    J Thorac Oncol; 2018 Feb; 13(2):258-272. PubMed ID: 29113949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of TGF-β in pleural effusions for diagnosis and prognostic stratification of malignant pleural mesothelioma.
    Stockhammer P; Ploenes T; Theegarten D; Schuler M; Maier S; Aigner C; Hegedus B
    Lung Cancer; 2020 Jan; 139():124-132. PubMed ID: 31778960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD26-mediated regulation of periostin expression contributes to migration and invasion of malignant pleural mesothelioma cells.
    Komiya E; Ohnuma K; Yamazaki H; Hatano R; Iwata S; Okamoto T; Dang NH; Yamada T; Morimoto C
    Biochem Biophys Res Commun; 2014 May; 447(4):609-15. PubMed ID: 24747072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leucine rich α2 glycoprotein 1 derived from malignant pleural mesothelioma cells facilitates macrophage M2 phenotypes.
    Wang D; Pei W; Liu Y; Mo R; Li X; Gu W; Su Y; Ye J; Xu J; Zhao D
    Exp Lung Res; 2024; 50(1):136-145. PubMed ID: 39033404
    [No Abstract]   [Full Text] [Related]  

  • 19. A novel PDX modeling strategy and its application in metabolomics study for malignant pleural mesothelioma.
    Chen Z; Yang C; Guo Z; Song S; Gao Y; Wang D; Mao W; Liu J
    BMC Cancer; 2021 Nov; 21(1):1235. PubMed ID: 34789172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs dysregulation in human malignant pleural mesothelioma.
    Balatti V; Maniero S; Ferracin M; Veronese A; Negrini M; Ferrocci G; Martini F; Tognon MG
    J Thorac Oncol; 2011 May; 6(5):844-51. PubMed ID: 21358347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.